Halper Sadeh LLC is Investigating Whether SAFT, NEUP, NRIM are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC is investigating Neuphoria Therapeutics regarding its proposed merger with Scancell Holdings plc to determine if the board is fulfilling its fiduciary duties. Under the terms of the proposed transaction, Neuphoria shareholders are set to own 14.5% of the combined company.
Key figures
- Combined company ownership
- 14.5%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.